KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,806,000 | -6.5% | 238,412 | -9.5% | 0.03% | -13.5% |
| Q3 2021 | $3,000,000 | -13.7% | 263,412 | +5.5% | 0.04% | -7.5% |
| Q2 2021 | $3,477,000 | -16.4% | 249,617 | +11.1% | 0.04% | -25.9% |
| Q1 2021 | $4,158,000 | -26.0% | 224,617 | -29.4% | 0.05% | -31.6% |
| Q4 2020 | $5,621,000 | +10.7% | 318,118 | -4.0% | 0.08% | +2.6% |
| Q3 2020 | $5,079,000 | +175.0% | 331,539 | +357.4% | 0.08% | +175.0% |
| Q2 2020 | $1,847,000 | -56.9% | 72,477 | -81.3% | 0.03% | -50.0% |
| Q4 2019 | $4,285,000 | +38.9% | 387,427 | +6.8% | 0.06% | +24.4% |
| Q3 2019 | $3,086,000 | +7.2% | 362,621 | +70.5% | 0.04% | +21.6% |
| Q2 2019 | $2,879,000 | +21.2% | 212,621 | +61.7% | 0.04% | +19.4% |
| Q1 2019 | $2,375,000 | +62.3% | 131,502 | +56.0% | 0.03% | +138.5% |
| Q2 2018 | $1,463,000 | – | 84,313 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |